-3.0% · 90d
$4.58
-0.04 (-0.87%)
News
(1)March 2026
PolyPid Ltd. — 6-K Filing
PYPDPolyPid Ltd.
# 🧾 What This Document Is This is a **6-K filing**, which is a report foreign companies like Israel-based PolyPid use to announce major news to the U.S. SEC and investors. Attached is a **press release** from March 31, 2026, announcing a huge step: they've started submitting their application to th
Read summaryView on SEC EDGAR
Peers in Biotechnology
VRTX#1
Vertex Pharmaceuticals Incorporated
$113.64B+0.64%
REGN#2
Regeneron Pharmaceuticals, Inc.
$78.80B-0.99%
ARGX#3
argenx SE
$49.22B+1.97%
ALNY#4
Alnylam Pharmaceuticals, Inc.
$42.61B-1.82%
ONC#5
BeOne Medicines AG
$34.75B+0.39%
INSM#6
Insmed Incorporated
$34.45B-0.37%
RPRX#7
Royalty Pharma plc
$27.86B+0.84%
BNTX#8
BioNTech SE
$23.26B-0.11%
ROIV#9
Roivant Sciences Ltd.
$20.38B+1.10%
MRNA#10
Moderna, Inc.
$20.34B-1.57%